People

Adrian Rawcliffe is a Wave director and CEO of Etiome. He previously led Adaptimmune, following service as its CFO, and held finance and business-development leadership roles at GSK and its former SR One venture business. He qualified as a chartered accountant at PricewaterhouseCoopers and earned a natural-sciences degree at Durham University.